Have a personal or library account? Click to login
Phenolic compounds of Iris adriatica and their antimycobacterial effects Cover

References

  1. 1. B. Mitić, Iris adriatica (Iridaceae), a new species from Dalmatia (Croatia), Phyton42 (2002) 305–314.
  2. 2. The Plant List. Version 1.1 (2013); http://www.theplantlist.org; last access date January 23, 2019
  3. 3. E. Wollenweber, J. F. Stevens, K. Klimo, J. Knauft, N. Frank and C. Gerhauser, Cancer chemopreventive in vitro activities of isoflavones isolated from Iris germanica, Planta Med.69 (2003) 15–20; https://doi.org/10.1055/s-2003-3703010.1055/s-2003-3703012567273
  4. 4. G.-Y. Xie, Y. Zhu, P. Shu, X.-Y. Qin, G. Wu, Q. Wang and M.-J. Qin, Phenolic metabolite profiles and antioxidants assay of three Iridaceae medicinal plants for traditional Chinese medicine “She-gan” by on-line HPLC–DAD coupled with chemiluminescence (CL) and ESI-Q-TOF-MS/MS, J. Pharmaceut. Biomed.98 (2014) 40–51. https://doi.org/10.1016/j.jpba.2014.05.00810.1016/j.jpba.2014.05.00825106824
  5. 5. S. H. Wani, B. A. Padder, T. Mokhdomi, J. I. Mir, H. A. Bhat, Q. P. Hassan and R. A. Qadri, Antiproliferative activity of methanolic extracts of different Iris plant species against A549 and Caco-2 cell lines, J. Pharmacogn. Phytochem.6 (2017) 1034–1037.
  6. 6. F. Conforti, D. Rigano, F. Menichini, M. R. Loizzo and F. Senatore, Protection against neurodegenerative diseases of Iris pseudopumila extracts and their constituents, Fitoterapia80 (2009) 62–67; https://doi.org/10.1016/j.fitote.2008.10.00510.1016/j.fitote.2008.10.00519000749
  7. 7. D. G. Spoerke Jr. and S. C. Smolinske, Toxicity of Houseplants, 1st ed., CRC Press, Boca Raton 1990.
  8. 8. F. Alperth, B. Mitić, S. Mayer, Ž. Maleš, O. Kunert, D. Hruševar and F. Bucar, Metabolic profiling of rhizomes of native populations of the strictly endemic Croatian species Iris adriatica, Plant Biosyst.153 (2019) 317–324; https://doi.org/10.1080/11263504.2018.147890610.1080/11263504.2018.1478906
  9. 9. D. Bukvički, M. Novaković, N. Ab Ghani, P. D. Marin and Y. Asakawa, Secondary metabolites from endemic species Iris adriatica Trinajstić ex Mitić (Iridaceae), Nat. Prod. Res.32 (2018) 1849–1852; https://doi.org/10.1080/14786419.2017.140230910.1080/14786419.2017.140230929126369
  10. 10. S. R. M. Ibrahim, G. A. Mohamed, M. F. Zayed and S. A. Ross, 8-Hydroxyirilone 5-methyl ether and 8-hydroxyirilone, new antioxidant and α-amylase inhibitors isoflavonoids from Iris germanica rhizomes, Bioorg. Chem.70 (2017) 192–198; https://doi.org/10.1016/j.bioorg.2016.12.01010.1016/j.bioorg.2016.12.01028069265
  11. 11. S. Lutter, K. Schmalbach, H. L. Esch and L. Lehmann, The isoflavone irilone contributes to the estrogenic potential of dietary supplements containing red clover, Arch. Toxicol.88 (2014) 309–321; https://doi.org/10.1007/s00204-013-1114-510.1007/s00204-013-1114-523982890
  12. 12. Jyotshna, P. Khare and K. Shanker, Mangiferin: A review of sources and interventions for biological activities, BioFactors,42 (2016) 504–514; https://doi.org/10.1002/biof.130810.1002/biof.130827658353
  13. 13. C. Cao, M. Su and F. Zhou, Mangiferin inhibits hippocampal NLRP3 inflammasome and exerts antidepressant effects in a chronic mild stress mice model, Behav. Pharmacol.28 (2017) 356–364; https://doi.org/10.1097/FBP.000000000000030510.1097/FBP.000000000000030528410265
  14. 14. World Health Organization, Editor, Global Tuberculosis Report 2018, ISBN: 978-92-4-156564-6.
  15. 15. L. Fernandez and R. E. W. Hancock, Adaptive and mutational resistance: Role of porins and efflux pumps in drug resistance, Clin. Microbiol. Rev.25 (2012) 661–681; https://doi.org/10.1128/CMR.00043-1210.1128/CMR.00043-12348574923034325
  16. 16. D. J. Newman and G. M. Cragg, Natural products as sources of new drugs from 1981 to 2014, J. Nat. Prod.79 (2016) 629–661; https://doi.org/10.1021/acs.jnatprod.5b0105510.1021/acs.jnatprod.5b0105526852623
  17. 17. S. H. Wani, A. Amin, M. A. Rather, J. A. Parray, Q. Parvaiz and R. A. Qadri, Antibacterial and phyto-chemical screening of different extracts of five Iris species growing in Kashmir, J. Pharm. Res.5 (2012) 3376–3378.
  18. 18. F.-C. Czygan, D. Frohne, K. Hiller, C. Holtzel and A. Nagell, Herbal drugs and phytopharmaceuticals - A Handbook for Pratice on a Scientific Basis (Eds. M. Wichtl), 3rd ed., Medpharm - Scientific Publishers, Stuttgart 2004, pp. 312–314.
  19. 19. F. Alperth, Phytochemische und mikrobiologische Untersuchungen an Iris adriatica, Diploma thesis, Faculty of Natural Sciences, University of Graz, 2017.
  20. 20. D. Lechner, S. Gibbons and F. Bucar, Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis, J. Antimirob. Chemoth.62 (2008) 345–348; https://doi.org/10.1093/jac/dkn17810.1093/jac/dkn17818430720
  21. 21. S. H. Wani, S. A. Lone, M. F. Mustafa, J. I. Mir, R. A. Qadri and Q. P. Hassan, Evaluation of prominent isoflavonoids of iris plant as futuristic cancer drug components, Int. J. Botany Stud. 2 (2017) 129–134.
  22. 22. G-Y. Xie, X-Y. Qin, R. Lui, Q. Wang, B-B. Lin, G-K. Wang, G-K. Xu, R. Wen and M-J. Qin, New isoflavones with cytotoxic activity from the rhizomes of Iris germanica L., Nat. Prod. Res. 27 (2013) 2173–2177; https://doi.org/10.1080/14786419.2013.79646810.1080/14786419.2013.79646823662687
DOI: https://doi.org/10.2478/acph-2019-0037 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 673 - 681
Accepted on: Mar 17, 2019
Published on: Oct 21, 2019
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2019 Sandra Ochensberger, Fabian Alperth, Božena Mitić, Olaf Kunert, Stefanie Mayer, Maria Ferreira Mourão, Ivana Turek, Simon Vlad Luca, Krystyna Skalicka-Woźniak, Željan Maleš, Dario Hruševar, Ivan Duka, Franz Bucar, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.